Clinical trial · Observational

Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer

Identify the Clinical Significance and Potential Implications of PWC in Patients With Pancreatic Cancer

NCT01127815CI-TRIAL-00003471unknownClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Pancreatic cancer is a disease with an extremely poor prognosis. Such poor results are largely due to a high incidence of local or peritoneal recurrence even after curative R0 resection. If occult microscopic metastasis or residual cancer could be predicted correctly and identify the high risk of peritoneal recurrence, we may have chance to treat these patients by different multimodal locoregional or adjuvant therapy to improve the treatment outcome.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Pancreatic Cancer	Malignant Pancreatic Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 20 Years
Maximum age: 90 Years

Show eligibility criteria text

Inclusion Criteria:

* Patients with pancreatic cancers, other non-ductal pancreatic cancers , and benign pancreatic tumors (as negative control population) operated in Surgical Department after IRB proof and receiving patients' informed consent.

Exclusion Criteria:

* Pregnant women

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Mar 1, 2010
Primary completion: Mar 1, 2011
Completion: Dec 1, 2011
First posted: May 21, 2010
Last update posted: May 21, 2010
Enrollment: 300 (estimated)
Lead sponsor: National Taiwan University Hospital OTHER
Keywords: Peritoneal washing cytology, pancreatic cancer, peritoneal metastasis, anoikis, to determine the relationship between PWC results and clinicopathologic parameters of pancreatic cancers, to identify the predictive value of PWC and postoperative drainage cytology on the peritoneal recurrence or outcomes, to dissect the molecular mechanism of peritoneal recurrence, especially on the PWC-inducing peritoneal seeding process.

Data updated 22 days agoSource updated May 21, 2010source: clinicaltrials

Locations

Locations by country (0)

No location posted.

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.